group 11-15

clinical stage company acquired by abbvie

antibody drug conjugates used in cancer treatment

targets cancer cells and cancer cells only via the use of cancer-killing toxins conjugated to cancer cell antibodies

clinical stage oncology company focused on developing next gen radiopharmaceuticals as precision medecine

Targeted Alpha Therapies with Fast-ClearTM Linker technology to connect alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumours

clinical stage biopharmaceutical company

latform includes multiple antibody technologies – primarily for the treatment of cancer. o mAbs, ADCs, multi-specific Abs (DART® and TRIDENT®) which includes Next-Gen T-Cell engagers

clinical stage biopharmaceutical company focused on utilizing their tech to develop rna therapeutics

Proprietary Antibody Oligonucleotide Conjugates (AOC ), which combines the specificity of monoclonal antibodies and the precision of oligonucleotides, to unlock the treatment for rare muscle diseases and for other rare and common diseases.

clinical stage biopharmaceutical company that combines technological and therapeutics based approach

transcon (transient conjugation) technology

-advanced cellular engineering with proprietary genetic and epigenetic reprogramming technologies -targeting solid tumors with innovative therapies like lyl979

pioneers in t cell programming for the treatment of solid tumors

glonal biotech company focused on using genetics and molecular biology to develop for rare disease

-enzyme replacement therapy: providing synthetic copies of missing proteins to people with genetic conditions -using adeno associated virus gene therapy for dna to cells

pioneed and leader in cell therapy -has global collaboration in china, us, japan and europe

car-t cell therapies to improve cancers such as multiple myeloma

discovery and clinical stage biopharmaceutical company

-ultracar-t cells -focused on the development of gene and cell therapies for immuno-oncology, autoimmune and infectious diseases -done through precision immunology with a framework of multifunctional therapies designed to work in combination

late stage clinical biotech

antibodies that target misfolded proteins, small molecules and vaccines

clinical stage biopharmaceutical, pioneering immuno-neurology, using insights into human genetics, immunology and neuroscience

monoclonal antibodies

clinical stage biopharmaceutical company